Remove Big Data Remove Doctor Remove Life Science
article thumbnail

AI, big data and real world evidence – the challenges and opportunities

pharmaphorum

We are doing that with a good number of rare diseases already both in respiratory diseases and neurology with different life sciences companies in different countries.”. BREATHE’s Jenni Quint said that the power is not just in information from wearables but the ability to link them with other data. About BREATHE.

Big Data 104
article thumbnail

New technologies fuel advancements in digital health

Pharmaceutical Technology

Services such as Personal Health Records and diagnostic apps collect, store and analyse patient data, which assists healthcare practitioners with diagnosis as well as enabling them to create tailored treatment plans based on the needs of the patient. Hamilton: Canada’s emerging leader in life sciences research and commercialization.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digitalising drug discovery

pharmaphorum

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. on Big data: astronomical or genomical? ,

article thumbnail

From Wearables to AI: Digital Health Tools Are Driving Cancer Care

XTalks

XTALKS WEBINAR: Digital Health Tools That Will Transform Cancer Treatment Live and On-Demand: Thursday, August 22, 2024, at 1pm EDT (10am PDT) Register for this webinar today to learn how pharmaceutical and life science technology companies are collaborating to harness digital health tools in oncology care delivery. Nanostics Inc.

article thumbnail

Medical Informatics: a bridge between two worlds

pharmaphorum

Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe. .

article thumbnail

Using technology to reassess the clinical trial landscape

pharmaphorum

“We can couple that with claims data and directly look at healthcare resource utilisation and see which doctors patients are visiting and if they are going to the emergency room or urgent care because of pain,” Sackman states. He oversees operations, including business development, sales and marketing, and people.

article thumbnail

Medical Informatics and Rare Disease: a bridge between two worlds

pharmaphorum

Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe.

Genomics 105